CLINICAL_TRIALS
trial_result
· 2020-08-13
Clinical Trial Update: Selinexor Treatment of Refractory Myeloma [Phase 2]
Summary
Phase 2 clinical trial update for selinexor in refractory multiple myeloma has completed; results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Karyopharm Therapeutics Inc | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-08-13